Home > VIIBRE - John P. Wikswo
VIIBRE - John P. Wikswo
Gordon A. Cain University Professor
A.B. Learned Professor of Living State Physics
Director, Vanderbilt Institute for Integrative Biosystems Research and Education
Professor of Biomedical Engineering
Professor of Molecular Physiology and Biophysics
Professor of Physics
For the past 40 years, John Wikswo has worked on measurements and modeling in bioengineering and electrophysiology, initially at the scale of humans and dogs, then with rodents, and more recently at the level of nanoliter bioreactors and individual cells. He explored in depth the relationship between cardiac electric and magnetic fields and the generation of the vector magnetocardiogram. With his collaborators, he made the first measurements of the magnetic field of a single axon and a single skeletal muscle fiber. All of these studies provided key insights into the parameters that relate the intracellular action currents to the transmembrane potential and extracellular electric and magnetic fields. His group played a central role in demonstrating the part performed by tissue anisotropy in the response of cardiac tissue to strong electric shocks and the behavior of cardiac virtual electrodes, which are explained by the doubly anisotropic bidomain of cardiac electrical activity. He also participated in pioneering magnetic measurements of the magnetoenterogram, a non-invasive recording of the magnetic field of the electrical activity in the human gastrointestinal tract. He then spent a decade exploring the capabilities of superconducting quantum interference device (SQUID) magnetometers for non-destructive testing of plastics and corroding aluminum.
He is the founding Director of the Vanderbilt Institute for Integrative Biosystems Research and Education (VIIBRE), which was created in 2001 with a $5 million, five-year grant from the Vanderbilt Academic Venture Capital Fund to foster and enhance interdisciplinary research in the biophysical sciences, bioengineering, and medicine at Vanderbilt. Within VIIBRE, he has focused on building on-campus collaborations to use microfabrication to create and utilize devices to instrument and control single cells and small collections of cells, and to provide data for parameterization of models of biological processes. In the past 12 years, VIIBRE has played a central role in bringing to Vanderbilt grants and contracts totaling more than $68 million.
VIIBRE projects include cellular biosensors, nanoliter bioreactors, chemotaxis devices, and models for cancer research; identification of chemical and biological warfare defense agents and infectious pathogens; new technologies for tracking metabolic and signaling dynamics and deriving models; biomedical imaging; biological applications of nanosystems; and cellular/tissue bioengineering and biotechnology. Through each of these projects, Wikswo has supported and mentored multiple trainees from the Departments of Biomedical Engineering, Molecular Physiology & Biophysics, and Physics & Astronomy. VIIBRE coordinates its graduate and postdoctoral training with its Searle Systems Biology and Bioengineering Undergraduate Research Experience (SyBBURE Searle), a year-round, multiyear, undergraduate research program funded by Gideon Searle. These students participate in the full breadth of VIIBRE research activities.
Wikswo is now focusing his personal research effort on systems biology, primarily from the perspective of the optimization of automated systems for combined experimental control and inference of quantitative metabolic and signaling models and organs-on-a-chip to help us better span the breadth of spatiotemporal scales of systems biology and pharmacokinetics and pharmacodynamics. In this context, he and his colleagues are actively developing microfabricated devices for measuring cellular properties and controlling cellular behavior, fabrication of large-scale instruments and biomedical devices, analysis of data, design of experiments, and the development and application of mathematical models of cellular signaling and metabolism.
He has extensive experience with both industrial/academic collaborations, particularly in both Phase I and Phase II SBIRs, and large DARPA and DTRA projects. Wikswo has been awarded twenty-two patents and has multiple patents pending. He is involved in well-funded organ-on-chip collaborations with Harvard University, the Cleveland Clinic, Los Alamos National Laboratory, the University of California - San Francisco, Charité Universitätsmedizin Berlin, and CFD Research Corporation.